US29350E1047 - Common Stock
ENOCHIAN BIOSCIENCES INC
NASDAQ:ENOB (8/4/2023, 7:00:53 PM)
After market: 0.7 0 (0%)0.7
0 (0%)
Enochian Biosciences, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. The company is headquartered in Los Angeles, California and currently employs 11 full-time employees. The company went IPO on 2014-11-18. The firm is focused on developing allogeneic cell and gene therapies to promote stronger immune system responses for long-term or life-long cancer remission in cancers and to treat or cure infectious diseases, such as Human Immunodeficiency Virus (HIV) and Hepatitis B virus (HBV) infection. The Allogeneic Cell Therapy platform has a human immune system, which is designed to recognize the self and destroy otherness or non-self, such as bacteria, viruses and cancer cells. The Company’s product candidates include ENOB-HV-01, which utilizes a cellular- and immunotherapy approach that could provide both preventative and therapeutic vaccines for HIV and ENOB-DC-11, which is a genetically modified allogeneic dendritic cell therapeutic vaccine as product for long-term remission of solid tumors. The company is also exploring ENOB-HV-21, a treatment for HIV with allogeneic natural killer (NK) and gamma delta t-cells (GDT).
ENOCHIAN BIOSCIENCES INC
Century City Medical Plaza, 2080 Century City East
Los Angeles CALIFORNIA 90067
P: 14539179840.0
CEO: Mark Dybul
Employees: 11
Website: https://enochianbio.com/
Doomed biotech stocks are a major part of the natural cycle within the sector that results in a lot of failures.
It's time to start off Wednesday with an overview of all the biggest pre-market stock movers worth watching this morning!
LOS ANGELES, June 23, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc., a company developing gene-modified cell immunotherapies for...
LOS ANGELES, June 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc. (the Company) announces that it remains confident in submitting...
Here you can normally see the latest stock twits on ENOB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: